De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
LIMES Schlosskliniken Inkomsten in het verleden
Verleden criteriumcontroles 3/6
LIMES Schlosskliniken has been growing earnings at an average annual rate of 49.8%, while the Healthcare industry saw earnings growing at 3.6% annually. Revenues have been growing at an average rate of 33.5% per year. LIMES Schlosskliniken's return on equity is 23.2%, and it has net margins of 10.2%.
Belangrijke informatie
49.8%
Groei van de winst
49.8%
Groei van de winst per aandeel
| Healthcare Groei van de industrie | 15.7% |
| Inkomstengroei | 33.5% |
| Rendement op eigen vermogen | 23.2% |
| Nettomarge | 10.2% |
| Laatste winstupdate | 30 Jun 2024 |
Recente prestatie-updates uit het verleden
LIMES Schlosskliniken's (ETR:LIK) Problems Go Beyond Weak Profit
May 21
LIMES Schlosskliniken's (ETR:LIK) Promising Earnings May Rest On Soft Foundations
May 23Recent updates
LIMES Schlosskliniken's (ETR:LIK) Problems Go Beyond Weak Profit
May 21Why We Like The Returns At LIMES Schlosskliniken (ETR:LIK)
Apr 12Returns on Capital Paint A Bright Future For LIMES Schlosskliniken (ETR:LIK)
Sep 07Under The Bonnet, LIMES Schlosskliniken's (ETR:LIK) Returns Look Impressive
Dec 21LIMES Schlosskliniken AG's (ETR:LIK) Shares May Have Run Too Fast Too Soon
Sep 24LIMES Schlosskliniken's (ETR:LIK) Promising Earnings May Rest On Soft Foundations
May 23LIMES Schlosskliniken (ETR:LIK) Is Doing The Right Things To Multiply Its Share Price
Mar 24Here's Why LIMES Schlosskliniken (ETR:LIK) Can Manage Its Debt Responsibly
Nov 16Would LIMES Schlosskliniken (ETR:LIK) Be Better Off With Less Debt?
May 17Opbrengsten en kosten
Hoe LIMES Schlosskliniken geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 42 | 4 | 8 | 0 |
| 31 Mar 24 | 39 | 4 | 7 | 0 |
| 31 Dec 23 | 37 | 3 | 7 | 0 |
| 30 Sep 23 | 33 | 3 | 6 | 0 |
| 30 Jun 23 | 30 | 3 | 5 | 0 |
| 31 Mar 23 | 29 | 4 | 4 | 0 |
| 31 Dec 22 | 29 | 4 | 4 | 0 |
| 30 Sep 22 | 29 | 4 | 4 | 0 |
| 30 Jun 22 | 29 | 4 | 4 | 0 |
| 31 Mar 22 | 26 | 4 | 4 | 0 |
| 31 Dec 21 | 23 | 4 | 4 | 0 |
| 30 Sep 21 | 19 | 3 | 3 | 0 |
| 30 Jun 21 | 15 | 2 | 3 | 0 |
| 31 Mar 21 | 13 | 0 | 3 | 0 |
| 31 Dec 20 | 11 | -1 | 2 | 0 |
| 30 Sep 20 | 10 | -1 | 1 | 0 |
| 30 Jun 20 | 9 | -1 | 0 | 0 |
| 31 Mar 20 | 9 | -1 | 0 | 0 |
| 31 Dec 19 | 8 | -1 | 0 | 0 |
| 30 Sep 19 | 8 | -1 | 0 | 0 |
| 30 Jun 19 | 8 | -1 | 1 | 0 |
| 31 Mar 19 | 8 | -1 | 1 | 0 |
| 31 Dec 18 | 8 | -1 | 1 | 0 |
| 31 Dec 17 | 7 | -1 | 2 | 0 |
Kwaliteitswinsten: LIK has a high level of non-cash earnings.
Groeiende winstmarge: LIK's current net profit margins (10.2%) are lower than last year (11%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: LIK has become profitable over the past 5 years, growing earnings by 49.8% per year.
Versnelling van de groei: LIK's earnings growth over the past year (31.8%) is below its 5-year average (49.8% per year).
Winst versus industrie: LIK earnings growth over the past year (31.8%) exceeded the Healthcare industry 30.9%.
Rendement op eigen vermogen
Hoge ROE: LIK's Return on Equity (23.2%) is considered high.